Structure |
Chemical Name |
CAS |
MF |
![Levosimendan Nitrosogenin Impurities](/) |
Levosimendan Nitrosogenin Impurities |
|
|
![7-(ALPHA-BROMOACETAMIDO)CEPHALOSPORANIC ACID](/CAS/GIF/26973-80-8.gif) |
7-(ALPHA-BROMOACETAMIDO)CEPHALOSPORANIC ACID |
26973-80-8 |
C12H13BrN2O6S |
![Bumetanide Impurity 20](/) |
Bumetanide Impurity 20 |
|
|
![Rocuronium Bromide Impurity 28 、29](/) |
Rocuronium Bromide Impurity 28 、29 |
|
|
![Roxadustat Impurity 22](/) |
Roxadustat Impurity 22 |
|
|
![Olaparib Impurity 41](/) |
Olaparib Impurity 41 |
|
|
![Perospirone Impurity 22](/) |
Perospirone Impurity 22 |
|
|
![Perospirone Impurity 14](/CAS/20211123/GIF/87691-94-9.gif) |
Perospirone Impurity 14 |
87691-94-9 |
C15H20BrN3S |
![Dolutegravir Impurity 22](/) |
Dolutegravir Impurity 22 |
|
|
![Paxlovid Impurity 20](/) |
Paxlovid Impurity 20 |
|
|
![Related impurities 7 of fluoxetine sodium](/) |
Related impurities 7 of fluoxetine sodium |
|
|
![Revefenacin Impurity 16](/) |
Revefenacin Impurity 16 |
|
|
![Fondaparinux sodium impurity 8](/) |
Fondaparinux sodium impurity 8 |
|
|
![Fondaparinux sodium impurity 14](/) |
Fondaparinux sodium impurity 14 |
|
|
![Fondaparinux Sodium Impurity 9](/) |
Fondaparinux Sodium Impurity 9 |
|
|
![Oxacillin sodium Impurity D](/) |
Oxacillin sodium Impurity D |
|
|
![Piracetam IMPURITY](/) |
Piracetam IMPURITY |
|
|
![Nilotinib N-Oxide Impurity 4](/) |
Nilotinib N-Oxide Impurity 4 |
|
|
![sodium (6R,7S)-7-amino-7-methoxy-6-methyl-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate](/) |
sodium (6R,7S)-7-amino-7-methoxy-6-methyl-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
|
|
![Olodaterol Impurity 32](/) |
Olodaterol Impurity 32 |
|
|
![(R)-Lercanidipine Hydrochloride](/CAS/GIF/187731-34-6.gif) |
(R)-Lercanidipine Hydrochloride |
187731-34-6 |
C36H42ClN3O6 |
![2-Oxo Clopidogrel Hydrochloride
(Mixture of diastereomers)](/CAS/20180808/GIF/109904-27-0.gif) |
2-Oxo Clopidogrel Hydrochloride(Mixture of diastereomers) |
109904-27-0 |
C16H16ClNO3S |
![5-Hydroxy-6-methoxy-1-indanone](/CAS/GIF/127399-78-4.gif) |
5-Hydroxy-6-methoxy-1-indanone |
127399-78-4 |
C10H10O3 |
![Desfluoro Citalopram Oxalate](/CAS/GIF/1093072-86-6.gif) |
Desfluoro Citalopram Oxalate |
1093072-86-6 |
C22H24N2O5 |
![Didesmethyl Zolmitriptan](/CAS/GIF/139264-15-6.gif) |
Didesmethyl Zolmitriptan |
139264-15-6 |
C14H17N3O2 |
![Gabapentin Related Compound E](/CAS/GIF/67950-95-2.gif) |
Gabapentin Related Compound E |
67950-95-2 |
C9H14O4 |
![Hydroxy Bosentan](/CAS/GIF/253688-60-7.gif) |
Hydroxy Bosentan |
253688-60-7 |
C27H29N5O7S |
![Lisinopril S,S,S-Diketopiperazine](/CAS/GIF/328385-86-0.gif) |
Lisinopril S,S,S-Diketopiperazine |
328385-86-0 |
C21H29N3O4 |
![rac 4-Desmethoxy-4-nitro Omeprazole](/CAS/GIF/317807-10-6.gif) |
rac 4-Desmethoxy-4-nitro Omeprazole |
317807-10-6 |
C16H16N4O4S |
![trans 1-Benzyl-4-(4-fluorophenyl)-3-piperidinemethanol](/CAS/GIF/201855-60-9.gif) |
trans 1-Benzyl-4-(4-fluorophenyl)-3-piperidinemethanol |
201855-60-9 |
C19H22FNO |
![ETHYL 7-CHLORO-1-ETHYL-6-FLUORO-1,4-DIHYDRO-4-OXO-QUINOLINE-5-CARBOXYLATE](/CAS/GIF/70458-94-5.gif) |
ETHYL 7-CHLORO-1-ETHYL-6-FLUORO-1,4-DIHYDRO-4-OXO-QUINOLINE-5-CARBOXYLATE |
70458-94-5 |
C14H13ClFNO3 |
![Diltiazem impurity](/CAS/20180702/GIF/115992-91-1.gif) |
Diltiazem impurity |
115992-91-1 |
C17H18N2O3S |
![Raloxifene EP IMpurity](/CAS/20180702/GIF/CB33033132.gif) |
Raloxifene EP IMpurity |
1700655-64-6 |
C13H15ClN2O2S |
![Parecoxib Impurity M](/) |
Parecoxib Impurity M |
|
|
![Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro-](/CAS/20200119/GIF/1648791-23-4.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro- |
1648791-23-4 |
C29H43N5 |
![Linagliptin Impurity O](/) |
Linagliptin Impurity O |
|
|
![Linagliptin Impurity T](/) |
Linagliptin Impurity T |
|
|
![(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzamide](/CAS/20180629/GIF/CB33042204.gif) |
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzamide |
|
C18H22FN5O3 |
![Apremilast Impurity 2](/) |
Apremilast Impurity 2 |
|
|
![Etoricoxib Impurity 16](/) |
Etoricoxib Impurity 16 |
|
|
![Ibrutinib Impurity 2](/) |
Ibrutinib Impurity 2 |
|
|
![Mirabegron Impurity 14](/) |
Mirabegron Impurity 14 |
|
|
![Vonoprazan Impurity 1](/CAS/20180906/GIF/881732-90-7.gif) |
Vonoprazan Impurity 1 |
881732-90-7 |
C17H17N3O2S |
![Atenolol EP Impurity](/CAS/20180702/GIF/CB33050081.gif) |
Atenolol EP Impurity |
|
C14H22N2O3 |
![Cinacalcet Impurity 20](/) |
Cinacalcet Impurity 20 |
|
|
![Dapagliflozin Impurity 11](/) |
Dapagliflozin Impurity 11 |
|
|
![Dasatinib Impurity C](/) |
Dasatinib Impurity C |
|
|
![Etoricoxib impurity Q](/CAS/20210111/GIF/292067-97-1.gif) |
Etoricoxib impurity Q |
292067-97-1 |
C18H15ClN2S |
![Flucloxacillin Impurity](/) |
Flucloxacillin Impurity |
|
|
![Fluorometholone Impurity](/CAS/20211123/GIF/2796-99-8.gif) |
Fluorometholone Impurity |
2796-99-8 |
C23H31FO7S |
![Verapamil Impurity](/CAS/20180702/GIF/CB33050692.gif) |
Verapamil Impurity |
1551304-28-9 |
C12H19NO2 |
![Clopidogrel impurity reference substance](/CAS/20200119/GIF/CB33050788.gif) |
Clopidogrel impurity reference substance |
|
C15H14ClNO2S |
![Vildagliptin Impurity](/) |
Vildagliptin Impurity |
|
|
![Aloeemodin-ω-O-β-D-glucopyranoside](/) |
Aloeemodin-ω-O-β-D-glucopyranoside |
29010-56-8 |
C21H20O10 |
![ethyl 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate](/CAS/20200119/GIF/2029205-62-5.gif) |
ethyl 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
2029205-62-5 |
C26H25ClN4O4 |
![1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate](/CAS/20180702/GIF/1192651-80-1.gif) |
1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate |
1192651-80-1 |
C23H46N4O6S |
![Dihydroxyoxaliplatin(Oxaliplatin Impurity Ⅲ)](/) |
Dihydroxyoxaliplatin(Oxaliplatin Impurity Ⅲ) |
|
|
![cefditoren E-isomer(C=C)](/) |
cefditoren E-isomer(C=C) |
|
|
![Mixture of Lamivudine Impurity Ⅳ and Impurity Ⅴ](/) |
Mixture of Lamivudine Impurity Ⅳ and Impurity Ⅴ |
|
|
![2-Ethoxybenzimidohydrazide](/CAS/20200119/GIF/889943-46-8.gif) |
2-Ethoxybenzimidohydrazide |
889943-46-8 |
C9H13N3O |
![(E)-2-(6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)-2-phenylacetic acid](/CAS/20180703/GIF/CB33116217.gif) |
(E)-2-(6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)-2-phenylacetic acid |
|
C18H13NO5 |
![8-Epi-cyanocobalamin](/CAS/20210111/GIF/41325-63-7.gif) |
8-Epi-cyanocobalamin |
41325-63-7 |
C63H88CoN14O14P |
![Lamivudine Impurity 2](/CAS/20210111/GIF/200396-21-0.gif) |
Lamivudine Impurity 2 |
200396-21-0 |
C18H27N3O4S |
![Lamivudine Impurity 1](/CAS/20180906/GIF/1235712-40-9.gif) |
Lamivudine Impurity 1 |
1235712-40-9 |
C8H11N3O4S |
![Moxifloxacin Related Impurity 3](/) |
Moxifloxacin Related Impurity 3 |
|
|
![Bisoprolol EP Impurity Q](/CAS/20180629/GIF/1346604-00-9.gif) |
Bisoprolol EP Impurity Q |
1346604-00-9 |
C16H27NO4 |
![Levofloxacin N-Oxide](/CAS/20180629/GIF/117678-37-2.gif) |
Levofloxacin N-Oxide |
117678-37-2 |
C18H20FN3O5 |
![Oseltamivir EP Impurity A](/CAS/20200611/GIF/1391047-93-0.gif) |
Oseltamivir EP Impurity A |
1391047-93-0 |
C14H24N2O4 |
![Quetiapine EP Impurity N](/CAS/20180808/GIF/1800291-86-4.gif) |
Quetiapine EP Impurity N |
1800291-86-4 |
C29H41N5O3S |
![Ceftazidime Impurity](/) |
Ceftazidime Impurity |
|
|
![Chlorhexidine Digluconate Impurity N](/CAS/20200611/GIF/152504-10-4.gif) |
Chlorhexidine Digluconate Impurity N |
152504-10-4 |
C15H25ClN8 |
![S-Azetidin-3-yl ethanethioate HCl](/CAS/GIF/886615-18-5.gif) |
S-Azetidin-3-yl ethanethioate HCl |
886615-18-5 |
C5H9NOS |
![Olaparib Impurity C](/) |
Olaparib Impurity C |
|
|
![Olaparib Impurity F](/) |
Olaparib Impurity F |
|
|
![Dapoxetine Impurity 4](/) |
Dapoxetine Impurity 4 |
|
|
![Glycopyrrolate impurity 3](/) |
Glycopyrrolate impurity 3 |
|
|
![Lamotrigine impurity B](/) |
Lamotrigine impurity B |
|
|
![Ramosetron Impurity 3](/) |
Ramosetron Impurity 3 |
|
|
![Loratadine Impurity 1](/CAS/20200119/GIF/CB33127510.gif) |
Loratadine Impurity 1 |
|
C22H23ClN2O2 |
![Metoprolol IMpurity 6](/CAS/20200119/GIF/CB33127590.gif) |
Metoprolol IMpurity 6 |
|
C15H25NO3 |
![Pitavastatin Impurity 5](/) |
Pitavastatin Impurity 5 |
|
|
![Prasugrel Impurity C](/) |
Prasugrel Impurity C |
|
|
![Trifluridine Impurity 2](/) |
Trifluridine Impurity 2 |
|
|
![Cefazolin Impurity 4](/) |
Cefazolin Impurity 4 |
|
|
![Vonoprazan Impurity 3](/) |
Vonoprazan Impurity 3 |
|
|
![Cinacalcene Impurity I](/) |
Cinacalcene Impurity I |
|
|
![Valsartan Impurity 2](/CAS/20200119/GIF/CB33128113.gif) |
Valsartan Impurity 2 |
|
C24H29N5O3 |
![Istradefylline Impurity 2](/) |
Istradefylline Impurity 2 |
|
|
![Etoricoxib Impurity 3](/) |
Etoricoxib Impurity 3 |
|
|
![Apremilast Impurity 5](/CAS/20211123/GIF/200710-04-9.gif) |
Apremilast Impurity 5 |
200710-04-9 |
C11H13NO4 |
![Topiroxostat Imp.C](/) |
Topiroxostat Imp.C |
|
|
![(3R,4S)-1-(4-chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one](/CAS/20180629/GIF/1700622-08-7.gif) |
(3R,4S)-1-(4-chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-08-7 |
C24H21ClFNO3 |
![Rabeprazole Impurity 2](/CAS/20180808/GIF/1163685-31-1.gif) |
Rabeprazole Impurity 2 |
1163685-31-1 |
C11H15NO4 |
![Regorafenib Impurity 8](/) |
Regorafenib Impurity 8 |
|
|
![Flomoxef Impurity 5](/CAS/20200611/GIF/134237-56-2.gif) |
Flomoxef Impurity 5 |
134237-56-2 |
C25H23ClF2N2O6S |
![Ranitidine impurity](/CAS/20180629/GIF/CB33129741.gif) |
Ranitidine impurity |
94167-82-5 |
C10H18N2O |
![nicergoline impurity E](/) |
nicergoline impurity E |
|
|
![ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate](/CAS/20200119/GIF/CB33130105.gif) |
ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate |
|
C26H33NO5 |
![Tacrolimus Impurity C](/) |
Tacrolimus Impurity C |
|
|
![Levodopa impurity 5](/) |
Levodopa impurity 5 |
|
|